Roles of the Y chromosome genes in human cancers

Asian Journal of Andrology

Volumn 17, Issue 3, 2015, Pages 373-380

  Kido, Tatsuo ^a   Lau, Yun Fai ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

germ cell tumors; RBMY Y linked; somatic cancers; TSPY; Y chromosome

Indexed keywords

NUCLEOSOME ASSEMBLY PROTEIN 1; RNA BINDING MOTIF PROTEIN Y; RNA BINDING PROTEIN; TESTIS SPECIFIC PROTEIN Y; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; NUCLEAR PROTEIN; RBMY1A1 PROTEIN, HUMAN; TSPY1 PROTEIN, HUMAN;

AZOOSPERMIA; GENE EXPRESSION; GERM CELL TUMOR; HUMAN; NEOPLASM; NONHUMAN; REVIEW; RNA BINDING; SRY GENE; Y CHROMOSOME; GENE EXPRESSION REGULATION; GENETICS; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; Y CHROMOSOMAL INHERITANCE;

AZOOSPERMIA; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, Y; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, Y-LINKED; HUMANS; MALE; NEOPLASMS; NEOPLASMS, GERM CELL AND EMBRYONAL; NUCLEAR PROTEINS; RNA-BINDING PROTEINS;

EID: 84928992188     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.4103/1008-682X.150842     Document Type: Review

References (115)

1. Postma DS. Gender differences in asthma development and progression. Gend Med 2007; 4 Suppl B: S133-46
2. Townsend EA, Miller VM, Prakash YS. Sex differences and sex steroids in lung health and disease. Endocr Rev 2012; 33: 1-47
3. Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol 2014; 35: 347-69
4. Lockshin MD. Sex differences in autoimmune disease. Lupus 2006; 15: 753-6
5. Goldstein JM, Cherkerzian S, Tsuang MT, Petryshen TL. Sex differences in the genetic risk for schizophrenia: history of the evidence for sex-specific and sex-dependent effects. Am J Med Genet B Neuropsychiatr Genet 2013; 162B: 698-710
6. Wu YC, Hill RA, Gogos A, van den Buuse M. Sex differences and the role of estrogen in animal models of schizophrenia: interaction with BDNF. Neuroscience 2013; 239: 67-83
7. Werling DM, Geschwind DH. Sex differences in autism spectrum disorders. Curr Opin Neurol 2013; 26: 146-53
8. Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B, et al. Why are autism spectrum conditions more prevalent in males? PLoS Biol 2011; 9: e1001081
9. Luczak ED, Leinwand LA. Sex-based cardiac physiology. Annu Rev Physiol 2009; 71: 1-18
10. Ober C, Loisel DA, Gilad Y. Sex-specific genetic architecture of human disease. Nat Rev Genet 2008; 9: 911-22
11. Nakamura H, Ando K, Shinmyo T, Morita K, Mochizuki A, et al. Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-Analysis. Ann Thorac Cardiovasc Surg 2011; 17: 469-80
12. Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, et al. Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 2011; 29: 457-63
13. Arbeev KG, Ukraintseva SV, Arbeeva LS, Yashin AI. Difference between male and female cancer incidence rates: how can it be explained? In: Nikulin MS, Commenges D, Huber-Carol C, editors. Probability, Statistics and Modelling in Public Health: New York: Springer; 2006
14. Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF. Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev 2011; 20: 1629-37
15. Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, Cordum HS, Hillier L, et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 2003; 423: 825-37
16. Helena Mangs A, Morris BJ. The Human Pseudoautosomal Region (PAR): origin, function and future. Curr Genomics 2007; 8: 129-36
17. Ginalski K, Rychlewski L, Baker D, Grishin NV. Protein structure prediction for the male-specific region of the human Y chromosome. Proc Natl Acad Sci U S A 2004; 101: 2305-10
18. Jangravi Z, Alikhani M, Arefnezhad B, Sharifi Tabar M, Taleahmad S, et al. A fresh look at the male-specific region of the human Y chromosome. J Proteome Res 2013; 12: 6-22
19. Lahn BT, Page DC. Four evolutionary strata on the human X chromosome. Science 1999; 286: 964-7
20. The Ensembl Project. Human Body Map 2.0 data from Illumina. Available from: http://www.ensembl.info/blog/2011/05/24/human-bodymap-2-0-data-from-illumina/.[Accessed on 2014 Oct 11]
21. Bellott DW, Hughes JF, Skaletsky H, Brown LG, Pyntikova T, et al. Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators. Nature 2014; 508: 494-9
22. Lahn BT, Page DC. Functional coherence of the human Y chromosome. Science 1997; 278: 675-80
23. Soh YQ, Alfoldi J, Pyntikova T, Brown LG, Graves T, et al. Sequencing the mouse Y chromosome reveals convergent gene acquisition and amplification on both sex chromosomes. Cell 2014; 159: 800-13
24. Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 1990; 346: 240-4
25. Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R. Male development of chromosomally female mice transgenic for Sry. Nature 1991; 351: 117-21
26. Vogt PH, Edelmann A, Hirschmann P, Kohler MR. The azoospermia factor (AZF) of the human Y chromosome in Yq11: function and analysis in spermatogenesis. Reprod Fertil Dev 1995; 7: 685-93
27. Vogt PH, Falcao CL, Hanstein R, Zimmer J. The AZF proteins. Int J Androl 2008; 31: 383-94
28. Page DC. Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development 1987; 101 Suppl: 151-5
29. Salo P, Kaariainen H, Petrovic V, Peltomaki P, Page DC, et al. Molecular mapping of the putative gonadoblastoma locus on the Y chromosome. Genes Chromosomes Cancer 1995; 14: 210-4
30. Tsuchiya K, Reijo R, Page DC, Disteche CM. Gonadoblastoma: molecular definition of the susceptibility region on the Y chromosome. Am J Hum Genet 1995; 57: 1400-7
31. Svingen T, Koopman P. Building the mammalian testis: origins, differentiation, and assembly of the component cell populations. Genes Dev 2013; 27: 2409-26
32. Krausz C, Hoefsloot L, Simoni M, Tuttelmann F, European Academy of Andrology, et al. EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: state-of-The-Art 2013. Andrology 2014; 2: 5-19
33. The TCGA Research Network. Available from: http://www.cancergenome.nih.gov/.Downloaded on 31 Oct 2014
34. Arnemann J, Epplen JT, Cooke HJ, Sauermann U, Engel W, et al. A human Y-chromosomal DNA sequence expressed in testicular tissue. Nucleic Acids Res 1987; 15: 8713-24
35. Zhang JS, Yang-Feng TL, Muller U, Mohandas TK, de Jong PJ, et al. Molecular isolation and characterization of an expressed gene from the human Y chromosome. Hum Mol Genet 1992; 1: 717-26
36. Manz E, Schnieders F, Brechlin AM, Schmidtke J. TSPY-related sequences represent a microheterogeneous gene family organized as constitutive elements in DYZ5 tandem repeat units on the human Y chromosome. Genomics 1993; 17: 726-31
37. Giachini C, Nuti F, Turner DJ, Laface I, Xue Y, et al. TSPY1 copy number variation influences spermatogenesis and shows differences among Y lineages. J Clin Endocrinol Metab 2009; 94: 4016-22
38. Nickkholgh B, Noordam MJ, Hovingh SE, van Pelt AM, van der Veen F, et al. Y chromosome TSPY copy numbers and semen quality. Fertil Steril 2010; 94: 1744-7
39. Honecker F, Stoop H, de Krijger RR, Chris Lau YF, Bokemeyer C, et al. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol 2004; 203: 849-57
40. Lau YF, Li Y, Kido T. Role of the Y-located putative gonadoblastoma gene in human spermatogenesis. Syst Biol Reprod Med 2011; 57: 27-34
41. Schnieders F, Dork T, Arnemann J, Vogel T, Werner M, et al. Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet 1996; 5: 1801-7
42. Lau YF. Gonadoblastoma, testicular and prostate cancers, and the TSPY gene. Am J Hum Genet 1999; 64: 921-7
43. Kersemaekers AM, Honecker F, Stoop H, Cools M, Molier M, et al. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol 2005; 36: 512-21
44. Li Y, Tabatabai ZL, Lee TL, Hatakeyama S, Ohyama C, et al. The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors. Hum Pathol 2007; 38: 1470-81
45. Li Y, Vilain E, Conte F, Rajpert-De Meyts E, Lau YF. Testis-specific protein Y-encoded gene is expressed in early and late stages of gonadoblastoma and testicular carcinoma in situ. Urol Oncol 2007; 25: 141-6
46. Lau Y, Chou P, Iezzoni J, Alonzo J, Komuves L. Expression of a candidate gene for the gonadoblastoma locus in gonadoblastoma and testicular seminoma. Cytogenet Cell Genet 2000; 91: 160-4
47. Kido T, Lo RC, Li Y, Lee J, Tabatabai ZL, et al. The potential contributions of a Y-located protooncogene and its X homologue in sexual dimorphisms in hepatocellular carcinoma. Hum Pathol 2014; 45: 1847-58
48. Yin YH, Li YY, Qiao H, Wang HC, Yang XA, et al. TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma. Br J Cancer 2005; 93: 458-63
49. Gallagher WM, Bergin OE, Rafferty M, Kelly ZD, Nolan IM, et al. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies. Carcinogenesis 2005; 26: 1856-67
50. Kido T, Hatakeyama S, Ohyama C, Lau YF. Expression of the Y-Encoded TSPY is associated with progression of prostate cancer. Genes (Basel) 2010; 1: 283-93
51. Lau YF, Lau HW, Komuves LG. Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer. Cytogenet Genome Res 2003; 101: 250-60
52. Fratta E, Coral S, Covre A, Parisi G, Colizzi F, et al. The biology of cancer testis antigens: putative function, regulation and therapeutic potential. Mol Oncol 2011; 5: 164-82
53. Mengus C, Schultz-Thater E, Coulot J, Kastelan Z, Goluza E, et al. MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas. Int J Cancer 2013; 132: 2459-63
54. Sommermeyer D, Conrad H, Kronig H, Gelfort H, Bernhard H, et al. NY-ESO-1 antigen-reactive T cell receptors exhibit diverse therapeutic capability. Int J Cancer 2013; 132: 1360-7
55. Ozbun LL, You L, Kiang S, Angdisen J, Martinez A, et al. Identification of differentially expressed nucleolar TGF-beta1 target (DENTT) in human lung cancer cells that is a new member of the TSPY/SET/NAP-1 superfamily. Genomics 2001; 73: 179-93
56. Muto S, Senda M, Akai Y, Sato L, Suzuki T, et al. Relationship between the structure of SET/TAF-Ibeta/INHAT and its histone chaperone activity. Proc Natl Acad Sci U S A 2007; 104: 4285-90
57. D'Arcy S, Martin KW, Panchenko T, Chen X, Bergeron S, et al. Chaperone Nap1 shields histone surfaces used in a nucleosome and can put H2A-H2B in an unconventional tetrameric form. Mol Cell 2013; 51: 662-77
58. Park YJ, Luger K. The structure of nucleosome assembly protein 1. Proc Natl Acad Sci U S A 2006; 103: 1248-53
59. Loyola A, Almouzni G. Histone chaperones, a supporting role in the limelight. Biochim Biophys Acta 2004; 1677: 3-11
60. Seo SB, McNamara P, Heo S, Turner A, Lane WS, et al. Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 2001; 104: 119-30
61. Chae YC, Kim KB, Kang JY, Kim SR, Jung HS, et al. Inhibition of FoxO1 acetylation by INHAT subunit SET/TAF-Is induces p21 transcription. FEBS Lett 2014; 588: 2867-73
62. Li Y, Lau YF. TSPY and its X-encoded homologue interact with cyclin B but exert contrasting functions on cyclin-dependent kinase 1 activities. Oncogene 2008; 27: 6141-50
63. Oram SW, Liu XX, Lee TL, Chan WY, Lau YF. TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer 2006; 6: 154
64. Kandalaft LE, Zudaire E, Portal-Nunez S, Cuttitta F, Jakowlew SB. Differentially expressed nucleolar transforming growth factor-beta1 target (DENTT) exhibits an inhibitory role on tumorigenesis. Carcinogenesis 2008; 29: 1282-9
65. Tu Y, Wu W, Wu T, Cao Z, Wilkins R, et al. Antiproliferative autoantigen CDA1 transcriptionally up-regulates p21(Waf1/Cip1) by activating p53 and MEK/ERK1/2 MAPK pathways. J Biol Chem 2007; 282: 11722-31
66. Eyler CE, Wu Q, Yan K, MacSwords JM, Chandler-Militello D, et al. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 2011; 146: 53-66
67. Delbridge ML, Longepied G, Depetris D, Mattei MG, Disteche CM, et al. TSPY, the candidate gonadoblastoma gene on the human Y chromosome, has a widely expressed homologue on the X-implications for Y chromosome evolution. Chromosome Res 2004; 12: 345-56
68. Lau YF, Kido T, Li Y. The TSPT gene family. In: Lau YF, Chan WY, editors. The Y Chromosome and Male Germ Cell Biology in Health and Diseases. Hackensack: World Scientific Publishers; 2007. p. 73-90
69. Kido T, Lau YF. The human Y-encoded testis-specific protein interacts functionally with eukaryotic translation elongation factor eEF1A, a putative oncoprotein. Int J Cancer 2008; 123: 1573-85
70. Wang W, Nag S, Zhang X, Wang MH, Wang H, et al. Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications. Med Res Rev 2015; 35: 225-85
71. Chang YW, Traugh JA. Phosphorylation of elongation factor 1 and ribosomal protein S6 by multipotential S6 kinase and insulin stimulation of translational elongation. J Biol Chem 1997; 272: 28252-7
72. Sonenberg N. Translation factors as effectors of cell growth and tumorigenesis. Curr Opin Cell Biol 1993; 5: 955-60
73. Spilka R, Ernst C, Mehta AK, Haybaeck J. Eukaryotic translation initiation factors in cancer development and progression. Cancer Lett 2013; 340: 9-21
74. Kido T, Lau YF. The Y-located gonadoblastoma gene TSPY amplifies its own expression through a positive feedback loop in prostate cancer cells. Biochem Biophys Res Commun 2014; 446: 206-11
75. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 2005; 5: 210-22
76. Hersmus R, de Leeuw BH, Wolffenbuttel KP, Drop SL, Oosterhuis JW, et al. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD). Mol Cell Endocrinol 2008; 291: 1-10
77. McGlynn KA, Devesa SS, Graubard BI, Castle PE. Increasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol 2005; 23: 5757-61
78. Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol 2003; 170: 5-11
79. McGlynn KA, Cook MB. The epidemiology of testicular cancer. In: Foulkes WD, Cooney KA, editors. Male Reproductive Cancers. New York: Springer; 2010
80. Skakkebaek NE. Possible carcinoma-in-situ of the testis. Lancet 1972; 2: 516-7
81. Rajpert-De Meyts E. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 2006; 12: 303-23
82. Kristensen DM, Sonne SB, Ottesen AM, Perrett RM, Nielsen JE, et al. Origin of pluripotent germ cell tumours: the role of microenvironment during embryonic development. Mol Cell Endocrinol 2008; 288: 111-8
83. Skakkebaek NE, Berthelsen JG, Giwercman A, Muller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 1987; 10: 19-28
84. Oosterhuis JW, Looijenga LH, van Echten J, de Jong B. Chromosomal constitution and developmental potential of human germ cell tumors and teratomas. Cancer Genet Cytogenet 1997; 95: 96-102
85. Rajpert-De Meyts E, Bartkova J, Samson M, Hoei-Hansen CE, Frydelund-Larsen L, et al. The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS 2003; 111: 267-78
86. Hoei-Hansen CE, Kraggerud SM, Abeler VM, Kaern J, Rajpert-De Meyts E, et al. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers. Mol Cancer 2007; 6: 12
87. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, et al. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci U S A 2003; 100: 13350-5
88. Cools M, Stoop H, Kersemaekers AM, Drop SL, Wolffenbuttel KP, et al. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads. J Clin Endocrinol Metab 2006; 91: 2404-13
89. Rajpert-De Meyts E, Ottesen AM, Hoei-Hansen CE, Sonne SB, Leffers H, et al. Origin of testicular germ cell neoplasia: the role of sex chromosomes. In: Lau YF, Chan WY, editors. The Y Chromosome and Male Germ Cell Biology in Health and Diseases: Hackensack: World Scientific; 2007. p. 289-308
90. Kraggerud SM, Hoei-Hansen CE, Alagaratnam S, Skotheim RI, Abeler VM, et al. Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis. Endocr Rev 2013; 34: 339-76
91. Cossu-Rocca P, Zhang S, Roth LM, Eble JN, Zheng W, et al. Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis. Mod Pathol 2006; 19: 611-5
92. Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol 2005; 18 Suppl 2: S61-79
93. Pleskacova J, Hersmus R, Oosterhuis JW, Setyawati BA, Faradz SM, et al. Tumor risk in disorders of sex development. Sex Dev 2010; 4: 259-69
94. Shirakawa H, Kuronuma T, Nishimura Y, Hasebe T, Nakano M, et al. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. Int J Oncol 2009; 34: 649-56
95. Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, et al. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 2002; 62: 2220-6
96. Vogel T, Dechend F, Manz E, Jung C, Jakubiczka S, et al. Organization and expression of bovine TSPY. Mamm Genome 1997; 8: 491-6
97. Hughes JF, Skaletsky H, Pyntikova T, Graves TA, van Daalen SK, et al. Chimpanzee and human Y chromosomes are remarkably divergent in structure and gene content. Nature 2010; 463: 536-9
98. Schubert S, Dechend F, Skawran B, Kunze B, Winking H, et al. Silencing of the Y-chromosomal gene tspy during murine evolution. Mamm Genome 2000; 11: 288-91
99. Mazeyrat S, Mitchell MJ. Rodent Y chromosome TSPY gene is functional in rat and non-functional in mouse. Hum Mol Genet 1998; 7: 557-62
100. Kido T, Lau YF. The rat Tspy is preferentially expressed in elongated spermatids and interacts with the core histones. Biochem Biophys Res Commun 2006; 350: 56-67
101. Schubert S, Skawran B, Dechend F, Nayernia K, Meinhardt A, et al. Generation and characterization of a transgenic mouse with a functional human TSPY. Biol Reprod 2003; 69: 968-75
102. Kido T, Schubert S, Hatakeyama S, Ohyama C, Schmidtke J, et al. Expression of a Y-located human proto-oncogene TSPY in a transgenic mouse model of prostate cancer. Cell Biosci 2014; 4: 9
103. Skrisovska L, Bourgeois CF, Stefl R, Grellscheid SN, Kister L, et al. The testis-specific human protein RBMY recognizes RNA through a novel mode of interaction. EMBO Rep 2007; 8: 372-9
104. Dreumont N, Bourgeois CF, Lejeune F, Liu Y, Ehrmann IE, et al. Human RBMY regulates germline-specific splicing events by modulating the function of the serine/arginine-rich proteins 9G8 and Tra2-{beta}. J Cell Sci 2010; 123: 40-50
105. Elliott DJ, Millar MR, Oghene K, Ross A, Kiesewetter F, et al. Expression of RBM in the nuclei of human germ cells is dependent on a critical region of the Y chromosome long arm. Proc Natl Acad Sci U S A 1997; 94: 3848-53
106. Tsuei DJ, Hsu HC, Lee PH, Jeng YM, Pu YS, et al. RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts. Oncogene 2004; 23: 5815-22
107. Tsuei DJ, Lee PH, Peng HY, Lu HL, Su DS, et al. Male germ cell-specific RNA binding protein RBMY: a new oncogene explaining male predominance in liver cancer. PLoS One 2011; 6: e26948
108. Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, et al. The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet 2005; 77: 1034-43
109. Linger R, Dudakia D, Huddart R, Easton D, Bishop DT, et al. A physical analysis of the Y chromosome shows no additional deletions, other than Gr/Gr, associated with testicular germ cell tumour. Br J Cancer 2007; 96: 357-61
110. Graves JA. Sex chromosome specialization and degeneration in mammals. Cell 2006; 124: 901-14
111. Kato T, Miyata K, Sonobe M, Yamashita S, Tamano M, et al. Production of Sry knockout mouse using TALEN via oocyte injection. Sci Rep 2013; 3: 3136
112. Shpargel KB, Sengoku T, Yokoyama S, Magnuson T. UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development. PLoS Genet 2012; 8: e1002964
113. Forsberg LA, Rasi C, Malmqvist N, Davies H, Pasupulati S, et al. Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer. Nat Genet 2014; 46: 624-8
114. Wiktor AE, Van Dyke DL, Hodnefield JM, Eckel-Passow J, Hanson CA. The significance of isolated Y chromosome loss in bone marrow metaphase cells from males over age50 years. Leuk Res 2011; 35: 1297-300
115. Jansen R, Batista S, Brooks AI, Tischfield JA, Willemsen G, et al. Sex differences in the human peripheral blood transcriptome. BMC Genomics 2014; 15: 33